Skip to main content
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: J Thorac Oncol. 2020 Dec 31;16(4):601–609. doi: 10.1016/j.jtho.2020.12.011

Table 2:

Univariate and multivariate analysis of ctDNA VAF

Univariate analysis Multivariate analysis
Characteristic HR (95% CI) P-value HR 95% CI P-value
Histology 0.94 (0.70 – 1.27) 0.694
Immunotherapy exposure 1.03 (0.75 – 1.43) 0.845
Visceral metastasis 1.66 (1.27 – 2.19) < 0.001 1.48 (1.16 – 1.91) 0.002
CNS metastasis 1.33 (1.00 – 1.79) 0.053
RECIST SLD 1.05 (1.03 – 1.08) < 0.0001
CT volume 1.00 (1.00 – 1.00) < 0.0001 1.00 (1.00 – 1.00) < 0.001
TP53+ 1.58 (1.25 – 2.00) < 0.001 1.45 (1.16 – 1.80) 0.001
EGFR+ 1.19 (0.92 – 1.53) 0.179 1.36 (1.08 – 1.71) 0.009
KRAS+ 1.22 (0.91 – 1.64) 0.178